Ghent University Academic Bibliography

Your filters: cql: author="Arndt, Volker" or (type any "bookEditor issueEditor" and editor="Arndt, Volker")

Add to list
- Journal Article
- A1
- open access
Cancer treatment data available in European cancer registries : where are we and where are we going?

Francesco Giusti, Carmen Martos, Annalisa Trama, Manola Bettio, Arantza Sanvisens, Riccardo Audisio, Volker Arndt, Silvia Francisci, Carine Dochez, Josepa Ribes, et al.

(2023) FRONTIERS IN ONCOLOGY. 13.
Add to list
Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire

Marieke van Leeuwen, Jacobien M. Kieffer, Teresa E. Young, Neil K. Aaronson, Lonneke V. van de Poll-Franse, Maria Antonietta Annunziata, Volker Arndt, Juan Ignacio Arraras, Didier Autran, Hira Bani Hani, et al.

(2023) JOURNAL OF CANCER SURVIVORSHIP. 17(4). p.1111-1130
Add to list
- Journal Article
- A1
- open access
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A. O'Mara, Joe Dennis, Jonathan P. Tyrer, Daniel R. Barnes, Lesley McGuffog, Goska Leslie, Manjeet K. Bolla, et al.

(2021) NATURE COMMUNICATIONS. 12(1).
Add to list
- Journal Article
- A1
- open access
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

Helian Feng, Alexander Gusev, Bogdan Pasaniuc, Lang Wu, Jirong Long, Zomoroda Abu-full, Kristiina Aittomaki, Irene L. Andrulis, Hoda Anton-Culver, Antonis C. Antoniou, et al.

(2020) GENETIC EPIDEMIOLOGY. 44(5). p.442-468
Add to list
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Haoyu Zhang, Thomas U. Ahearn, Julie Lecarpentier, Daniel Barnes, Jonathan Beesley, Guanghao Qi, Xia Jiang, Tracy A. O’Mara, Ni Zhao, Manjeet K. Bolla, et al.

(2020) NATURE GENETICS. 52(6). p.572-581
Add to list
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Laura Fachal, Hugues Aschard, Jonathan Beesley, Daniel R. Barnes, Jamie Allen, Siddhartha Kar, Karen A. Pooley, Joe Dennis, Kyriaki Michailidou, Constance Turman, et al.

(2020) NATURE GENETICS. 52(1).
Add to list
- Journal Article
- A1
- open access
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Gisella Figlioli, Massimo Bogliolo, Irene Catucci, Laura Caleca, Sandra Viz Lasheras, Roser Pujol, Johanna I Kiiski, Taru A Muranen, Daniel R Barnes, Joe Dennis, et al.

(2019) NPJ BREAST CANCER. 5.
Add to list
- Journal Article
- A1
- open access
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Manuel A Ferreira, Eric R Gamazon, Fares Al-Ejeh, Kristiina Aittomaki, Irene L Andrulis, Hoda Anton-Culver, Adalgeir Arason, Volker Arndt, Kristan J Aronson, Banu K Arun, et al.

(2019) NATURE COMMUNICATIONS. 10.
Add to list
BRCA2 hypomorphic missense variants confer moderate risks of breast cancer

Hermela Shimelis, Romy LS Mesman, Catharina Von Nicolai, Asa Ehlen, Lucia Guidugli, Charlotte Martin, Fabienne MGR Calléja, Huong Meeks, Emily Hallberg, Jamie Hinton, et al.

(2017) CANCER RESEARCH. 77(11). p.2789-2799
Add to list
- Journal Article
- A1
- open access
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Roger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Sara Lindström, Shirley Hui, Audrey Lemaçon, Penny Soucy, Joe Dennis, et al.

(2017) NATURE GENETICS. 49(12). p.1767-1778

Academic Bibliography

Cancer treatment data available in European cancer registries : where are we and where are we going?

Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

BRCA2 hypomorphic missense variants confer moderate risks of breast cancer

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Contents

Support

Contact